Litcius/Paper detail

Ivarmacitinib Sulfate: First Approval

Susan J. Keam

2025Drugs9 citationsDOI

Topics & Concepts

MedicineAnkylosing spondylitisTofacitinibRheumatoid arthritisPsoriatic arthritisInternal medicineTumor necrosis factor alphaPsoriasisJanus kinase inhibitorDermatologyDermatology and Skin DiseasesAutoimmune and Inflammatory Disorders ResearchIL-33, ST2, and ILC Pathways
Ivarmacitinib Sulfate: First Approval | Litcius